Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multicentral Retrospective Analysis of Venetoclax-Based Treatments in AML and MDS: A Real-World Study by the Turkish Hematology Network Group.
Acar IH, Aslaner Ak M, Akyol G, Kars TU, Ipek Y, Uysal A, Atalay F, Senturk Yikilmaz A, Ekinci O, Ince I, Onec B, Keski H, Okay Ozgeyik M, Izmir Guner S, Terzi Demirsoy E, Bilgir O, Guvenc B. Acar IH, et al. Among authors: ekinci o. Medicina (Kaunas). 2024 Oct 4;60(10):1623. doi: 10.3390/medicina60101623. Medicina (Kaunas). 2024. PMID: 39459410 Free PMC article.
Impact of COVID-19 on Outcomes of Patients with Hematologic Malignancies: A Multicenter, Retrospective Study.
Acar IH, Guner SI, Ak MA, Gocer M, Ozturk E, Atalay F, Sincan G, Yikilmaz AS, Ekinci O, Ince I, Gulturk E, Demir N, Dogan A, Ipek Y, Guvenc B. Acar IH, et al. Among authors: ekinci o. Mediterr J Hematol Infect Dis. 2022 Nov 1;14(1):e2022074. doi: 10.4084/MJHID.2022.074. eCollection 2022. Mediterr J Hematol Infect Dis. 2022. PMID: 36425152 Free PMC article.
The Real-World Experience With Single Agent Ibrutinib in Relapsed/Refractory CLL.
Akpinar S, Dogu MH, Celik S, Ekinci O, Hindilerden IY, Dal MS, Davulcu EA, Tekinalp A, Hindilerden F, Ozcan BG, Hacibekiroglu T, Erkurt MA, Bagci M, Namdaroglu S, Korkmaz G, Bilgir O, Cagliyan GA, Ozturk HBA, Serin I, Tiryaki TO, Ozatli D, Korkmaz S, Ulas T, Eser B, Turgut B, Altuntas F. Akpinar S, et al. Among authors: ekinci o. Clin Lymphoma Myeloma Leuk. 2022 Mar;22(3):169-173. doi: 10.1016/j.clml.2021.09.010. Epub 2021 Sep 15. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34629286
Castleman Disease: A Multicenter Case Series from Turkey.
Gündüz E, Kırkızlar HO, Ümit EG, Karaman Gülsaran S, Özkocaman V, Özkalemkaş F, Candar Ö, Elverdi T, Küçükyurt S, Paydaş S, Çeneli Ö, Karakuş S, Maral S, Ekinci Ö, İpek Y, Kis C, Güven ZT, Akdeniz A, Celkan T, Eroğlu Küçükdiler AH, Akgün Çağlıyan G, Özçelik Şengöz C, Karataş A, Bulduk T, Özcan A, Belen Apak FB, Canbolat A, Kartal İ, Ören H, Töret E, Özdemir GN, Bakanay Öztürk ŞM. Gündüz E, et al. Among authors: ekinci o. Turk J Haematol. 2022 Jun 1;39(2):130-135. doi: 10.4274/tjh.galenos.2022.2021.0670. Epub 2022 Feb 18. Turk J Haematol. 2022. PMID: 35176839 Free PMC article.
Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkısh oncology group study.
Acar R, Paydaş S, Yıldırım M, Kılıçarslan E, Sahın U, Dogan A, Guven DC, Ekıncı O, Tıglıoglu M, Erdogan I, Elıbol T, Kızıloz H, Aykan MB, Sayın S, Kaptan K, Soydan E, Gokmen A, Esen R, Barısta I, Albayrak M, Erturk I, Yıldız B, Keskın GY, Aylı M, Karadurmus N. Acar R, et al. Among authors: ekinci o. J Cancer Res Ther. 2023 Apr;19(Supplement):S138-S144. doi: 10.4103/jcrt.jcrt_355_22. J Cancer Res Ther. 2023. PMID: 37147993 Free article.
International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report.
Ozatli D, Giden AO, Erkurt MA, Korkmaz S, Basci S, Ulas T, Turgut B, Yigenoglu TN, Hacibekiroglu T, Basturk A, Dal MS, Namdaroglu S, Hindilerden F, Hacioglu SK, Cagliyan GA, Ilhan G, Kacmaz M, Uysal A, Merter M, Ekinci O, Dursun FE, Tekinalp A, Demircioglu S, Sincan G, Acik DY, Akdeniz A, Ucar MA, Yeral M, Ciftciler R, Teke HU, Umit EG, Karakus A, Bilen Y, Yokus O, Albayrak M, Demir C, Okan V, Serefhanoglu S, Kartı S, Ozkurt ZN, Eser B, Aydogdu I, Kuku I, Cagirgan S, Sonmez M, Ozet G, Altuntas F. Ozatli D, et al. Among authors: ekinci o. Transfus Apher Sci. 2023 Apr;62(2):103662. doi: 10.1016/j.transci.2023.103662. Epub 2023 Feb 24. Transfus Apher Sci. 2023. PMID: 36842884 Review.
Pralatrexate experience in PTCL: A multicenter retrospective study from Turkey.
Sinan Dal M, Merdin A, Erkurt MA, Ekinci Ö, Albayrak M, Kabukcu Hacıoglu S, Kaya A, Dogu MH, Hindilerden F, Sarici A, Merter M, Reis Aras M, Akgun Caglıyan G, Kizil Cakar M, Aydogdu I, Kuku I, Korkmaz S, Ulas T, Eser B, Altuntas F. Sinan Dal M, et al. Among authors: ekinci o. J BUON. 2021 Jul-Aug;26(4):1536-1539. J BUON. 2021. PMID: 34565016 Free article.
Real-world data on the effectiveness and safety of Ixazomib-Lenalidomide-Dexamethasone therapy in relapsed/refractory multiple myeloma patients: a multicenter experience in Turkey.
Bakırtaş M, Dal MS, Yiğenoğlu TN, Giden AO, Serin I, Başcı S, Kalpakci Y, Korkmaz S, Ekinci O, Albayrak M, Basturk A, Ozatli D, Dogu MH, Hacıbekiroglu T, Çakar MK, Ulas T, Miskioglu M, Gulturk E, Eser B, Altuntas F. Bakırtaş M, et al. Among authors: ekinci o. J Chemother. 2023 Oct;35(6):563-569. doi: 10.1080/1120009X.2023.2208439. Epub 2023 May 21. J Chemother. 2023. PMID: 37211906
Efficacy and safety of G-CSF prophylaxis in patients with extensive-stage small cell lung cancer receiving chemoimmunotherapy.
Ilhan Y, Ucar G, Baser MN, Guzel HG, Efil SC, Demir B, Ercan Uzundal D, Karacelik T, Sever N, Balcik OY, Arvas H, Karadag I, Kadioglu A, Ekinci ÖB, Karacin C, Urakci Z, Kostek O, Karakurt Eryilmaz M, Yazici O, Sendur MAN, Ozturk B, Uncu D, Ergun Y. Ilhan Y, et al. Among authors: ekinci ob. Expert Opin Pharmacother. 2024 Aug;25(11):1555-1563. doi: 10.1080/14656566.2024.2391007. Epub 2024 Aug 11. Expert Opin Pharmacother. 2024. PMID: 39115275
The clinicopathological features and survival of Castleman disease: a multicenter Turkish study.
Yildiz J, Bagci M, Sayin S, Kaya A, Yilmaz F, Ekinci O, Dal MS, Basturk A, Aydogdu I, Albayrak M, Dogan A, Erkurt MA, Korkmaz S, Ulas T, Eser B, Altuntas F. Yildiz J, et al. Among authors: ekinci o. Eur Rev Med Pharmacol Sci. 2022 Feb;26(4):1131-1137. doi: 10.26355/eurrev_202202_28103. Eur Rev Med Pharmacol Sci. 2022. PMID: 35253168 Free article.
239 results